The Africa Centers for Disease Control and Prevention (Africa CDC) announced that nearly 2,000 deaths from mpox have been recorded in Africa since the beginning of 2024, even as the number of new cases shows a promising decline. As of September 2025, 29 African countries have reported 185,994 mpox cases since early 2024, with 51,969 confirmed and 1,987 deaths. Notably, Africa has already reported 105,697 cases in 2025 alone, surpassing the total cases from 2024. This decline in incidence follows intensified response efforts across the continent, marking a hopeful trend in the fight against the virus.
Key Developments and Data
Mpox, formerly known as monkeypox, is a rare viral disease identified initially in laboratory monkeys in 1958. It transmits mainly through body fluids, respiratory droplets, and contact with contaminated materials, causing symptoms such as fever, rash, and swollen lymph nodes. The ongoing outbreak has been declared a public health emergency of continental security by Africa CDC in August 2024 and a public health emergency of international concern by the World Health Organization (WHO).
Recent data from Africa CDC reveal a substantial reduction in confirmed cases, with average weekly counts dropping 52% from a peak of 1,441 in May 2025 to 695 cases over the past five weeks. Testing coverage has also improved significantly, rising from 30% to 66% of suspected cases tested in the last six weeks, which likely contributes to more accurate surveillance.
Expert Perspectives and Context
Yap Boum II, deputy incident manager for mpox at Africa CDC, underscored the encouraging trend while emphasizing the need for sustained efforts. Independent infectious disease specialists note that although the decline is positive, vigilance remains critical to prevent resurgence or underreporting.
Dr. Amina Hassan, an epidemiologist not involved in the Africa CDC report, explained, “The rise in testing and better case detection help us understand the outbreak dynamics more clearly, but gaps in healthcare access and community awareness in some regions could still obscure the true extent of transmission.”
Implications for Public Health and Daily Life
This progress offers a cautiously optimistic outlook for populations in affected regions. Enhanced testing and public health interventions provide practical benefits by enabling earlier diagnosis and targeted isolation measures. For the general public, awareness of mpox transmission routes—such as close physical contact and respiratory droplets—remains crucial. Simple preventive steps like avoiding contact with infected individuals or contaminated items can reduce risk.
Despite improvements, the high number of cases and deaths since 2024 highlights continuous challenges in managing infectious diseases across diverse settings with varying healthcare infrastructure.
Limitations and Balanced Reporting
While the Africa CDC’s data offer important insights, some limitations are inherent. Case reporting can be influenced by testing availability and healthcare-seeking behavior, leading to potential under- or overestimation. Additionally, fatalities reported might vary in definition or confirmation criteria across countries.
Conflicting viewpoints from some public health observers caution against premature conclusions that the outbreak is under control, stressing the importance of ongoing surveillance and vaccination campaigns where available. The unpredictable nature of viral outbreaks requires sustained international cooperation and resource allocation.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
-
-
Africa CDC. “Mpox deaths near 2,000 in Africa since 2024 amid recent decline in cases.” China Daily, 5 Sept. 2025.
- https://global.chinadaily.com.cn/a/202509/05/WS68ba42a2a3108622abc9f035.html
-